Biomedical Ethics Program, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231151766. doi: 10.1177/21501319231151766.
Polygenic risk testing examines variation across multiple genes to estimate a risk score for a particular disease, including risk scores for many common, chronic health conditions. Although polygenic risk information (PRI) may be a promising tool for enhancing preventive counseling and facilitating early identification of disease, its potential impact on primary-care encounters and disease prevention efforts has not been well characterized.
We conducted in-depth, semi-structured interviews of patients to assess their understandings of PRI and their beliefs about its relevance to disease prevention.
We completed interviews with 19 participants. Participants described enthusiasm for the generation of PRI and recognized its utility for disease prevention. Participants also described the value of PRI as limited if not corroborated by non-genetic risk factors. Finally, participants noted that PRI, by itself, would be insufficient as a trigger for initiating many preventive interventions.
PRI has the potential to become an important tool in primary care. However, patient views about PRI as well as the complexities of disease prevention in the primary care context may limit the impact of PRI on disease prevention.
多基因风险测试通过检测多个基因的变异来评估特定疾病的风险评分,包括许多常见慢性健康状况的风险评分。虽然多基因风险信息(PRI)可能是增强预防咨询和促进疾病早期识别的有前途的工具,但它对初级保健就诊和疾病预防工作的潜在影响尚未得到很好的描述。
我们对患者进行了深入的半结构化访谈,以评估他们对 PRI 的理解及其对疾病预防的相关性的看法。
我们完成了 19 名参与者的访谈。参与者对 PRI 的产生表示了热情,并认识到其在疾病预防方面的实用性。参与者还描述了 PRI 的价值是有限的,如果没有非遗传风险因素的佐证。最后,参与者指出,PRI 本身不足以作为启动许多预防干预措施的触发因素。
PRI 有可能成为初级保健的重要工具。然而,患者对 PRI 的看法以及初级保健环境中疾病预防的复杂性可能会限制 PRI 对疾病预防的影响。